Literature DB >> 10918259

Inhibition of motor unit firing during experimental muscle pain in humans.

M K Sohn1, T Graven-Nielsen, L Arendt-Nielsen, P Svensson.   

Abstract

Electromyographic activity was recorded in the masseter muscle to investigate whether the firing characteristics of single motor units (SMUs) were affected by muscle pain. Capsaicin was injected into the masseter to induce pain. The interspike interval (ISI) and recruitment threshold of SMUs were measured while subjects performed isometric contractions at 5, 7.5, 10, 15, and 20% of maximum voluntary contraction. All subjects were able to maintain a stable isometric force during pain, but the mean ISI was significantly increased without changing the recruitment threshold. In all the experimental conditions, the firing frequency increased with increasing force, and SMUs recruited at low force fired at higher rates for all force levels. These results suggest that acute stimulation of nociceptive muscle afferents inhibits SMU activity without changing recruitment order in the homonymous muscle. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918259     DOI: 10.1002/1097-4598(200008)23:8<1219::aid-mus10>3.0.co;2-a

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

1.  The influence of muscle pain and fatigue on the activity of synergistic muscles of the leg.

Authors:  Andrei Ciubotariu; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Eur J Appl Physiol       Date:  2003-12-18       Impact factor: 3.078

2.  Non-invasive assessment of single motor unit mechanomyographic response and twitch force by spike-triggered averaging.

Authors:  C Cescon; M Gazzoni; M Gobbo; C Orizio; D Farina
Journal:  Med Biol Eng Comput       Date:  2004-07       Impact factor: 2.602

3.  Experimental muscle pain changes motor control strategies in dynamic contractions.

Authors:  Ulysses F Ervilha; Dario Farina; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2005-06-11       Impact factor: 1.972

4.  Experimental muscle pain results in reorganization of coordination among trapezius muscle subdivisions during repetitive shoulder flexion.

Authors:  Deborah Falla; Dario Farina; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2006-10-19       Impact factor: 1.972

Review 5.  Neural and muscular factors associated with motor impairment in neck pain.

Authors:  Deborah Falla; Dario Farina
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

6.  Motor unit recruitment strategies are altered during deep-tissue pain.

Authors:  Kylie Tucker; Jane Butler; Thomas Graven-Nielsen; Stephan Riek; Paul Hodges
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

7.  Glutamate and capsaicin effects on trigeminal nociception I: Activation and peripheral sensitization of deep craniofacial nociceptive afferents.

Authors:  David K Lam; Barry J Sessle; James W Hu
Journal:  Brain Res       Date:  2008-11-19       Impact factor: 3.252

8.  Pain and motor function in carpal tunnel syndrome: a clinical, neurophysiological and psychophysical study.

Authors:  S Tamburin; C Cacciatori; S Marani; G Zanette
Journal:  J Neurol       Date:  2008-07-21       Impact factor: 4.849

9.  Assessment of the potential role of muscle spindle mechanoreceptor afferents in chronic muscle pain in the rat masseter muscle.

Authors:  James P Lund; Somayeh Sadeghi; Tuija Athanassiadis; Nadia Caram Salas; François Auclair; Benoît Thivierge; Isabel Arsenault; Pierre Rompré; Karl-Gunnar Westberg; Arlette Kolta
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

10.  TRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP.

Authors:  Marina Quartu; Maria Pina Serra; Marianna Boi; Laura Poddighe; Cristina Picci; Roberto Demontis; Marina Del Fiacco
Journal:  J Anat       Date:  2016-07-26       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.